PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors

Ventral tegmental area dopamine neurons control reward-driven learning, and their dysregulation can lead to psychiatric disorders. Tonic and phasic activity of these dopaminergic neurons depends on cholinergic tone and activation of nicotinic acetylcholine receptors (nAChRs), particularly those cont...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 33; no. 14; pp. 6203 - 6211
Main Authors Melis, Miriam, Scheggi, Simona, Carta, Gianfranca, Madeddu, Camilla, Lecca, Salvatore, Luchicchi, Antonio, Cadeddu, Francesca, Frau, Roberto, Fattore, Liana, Fadda, Paola, Ennas, M Grazia, Castelli, M Paola, Fratta, Walter, Schilstrom, Bjorn, Banni, Sebastiano, De Montis, M Graziella, Pistis, Marco
Format Journal Article
LanguageEnglish
Published United States Society for Neuroscience 03.04.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Ventral tegmental area dopamine neurons control reward-driven learning, and their dysregulation can lead to psychiatric disorders. Tonic and phasic activity of these dopaminergic neurons depends on cholinergic tone and activation of nicotinic acetylcholine receptors (nAChRs), particularly those containing the β2 subunit (β2*-nAChRs). Nuclear peroxisome proliferator-activated receptors type-α (PPARα) tonically regulate β2*-nAChRs and thereby control dopamine neuron firing activity. However, it is unknown how and when PPARα endogenous ligands are synthesized by dopamine cells. Using ex vivo and in vivo electrophysiological techniques combined with biochemical and behavioral analysis, we show that activation of α7-nAChRs increases in the rat VTA both the tyrosine phosphorylation of the β2 subunit of nAChRs and the levels of two PPARα endogenous ligands in a Ca(2+)-dependent manner. Accordingly, in vivo production of endogenous PPARα ligands, triggered by α7-nAChR activation, blocks in rats nicotine-induced increased firing activity of dopamine neurons and displays antidepressant-like properties. These data demonstrate that endogenous PPARα ligands are effectors of α7-nAChRs and that their neuromodulatory properties depend on phosphorylation of β2*-nAChRs on VTA dopamine cells. This reveals an autoinhibitory mechanism aimed at reducing dopamine cell overexcitation engaged during hypercholinergic drive. Our results unveil important physiological functions of nAChR/PPARα signaling in dopamine neurons and how behavioral output can change after modifications of this signaling pathway. Overall, the present study suggests PPARα as new therapeutic targets for disorders associated with unbalanced dopamine-acetylcholine systems.
AbstractList Ventral tegmental area dopamine neurons control reward-driven learning, and their dysregulation can lead to psychiatric disorders. Tonic and phasic activity of these dopaminergic neurons depends on cholinergic tone and activation of nicotinic acetylcholine receptors (nAChRs), particularly those containing the β2 subunit (β2*-nAChRs). Nuclear peroxisome proliferator-activated receptors type-α (PPARα) tonically regulate β2*-nAChRs and thereby control dopamine neuron firing activity. However, it is unknown how and when PPARα endogenous ligands are synthesized by dopamine cells. Using ex vivo and in vivo electrophysiological techniques combined with biochemical and behavioral analysis, we show that activation of α7-nAChRs increases in the rat VTA both the tyrosine phosphorylation of the β2 subunit of nAChRs and the levels of two PPARα endogenous ligands in a Ca(2+)-dependent manner. Accordingly, in vivo production of endogenous PPARα ligands, triggered by α7-nAChR activation, blocks in rats nicotine-induced increased firing activity of dopamine neurons and displays antidepressant-like properties. These data demonstrate that endogenous PPARα ligands are effectors of α7-nAChRs and that their neuromodulatory properties depend on phosphorylation of β2*-nAChRs on VTA dopamine cells. This reveals an autoinhibitory mechanism aimed at reducing dopamine cell overexcitation engaged during hypercholinergic drive. Our results unveil important physiological functions of nAChR/PPARα signaling in dopamine neurons and how behavioral output can change after modifications of this signaling pathway. Overall, the present study suggests PPARα as new therapeutic targets for disorders associated with unbalanced dopamine-acetylcholine systems.
Ventral tegmental area dopamine neurons control reward-driven learning, and their dysregulation can lead to psychiatric disorders. Tonic and phasic activity of these dopaminergic neurons depends on cholinergic tone and activation of nicotinic acetylcholine receptors (nAChRs), particularly those containing the β2 subunit (β2*-nAChRs). Nuclear peroxisome proliferator-activated receptors type-α (PPARα) tonically regulate β2*-nAChRs and thereby control dopamine neuron firing activity. However, it is unknown how and when PPARα endogenous ligands are synthesized by dopamine cells. Using ex vivo and in vivo electrophysiological techniques combined with biochemical and behavioral analysis, we show that activation of α7-nAChRs increases in the rat VTA both the tyrosine phosphorylation of the β2 subunit of nAChRs and the levels of two PPARα endogenous ligands in a Ca 2+ -dependent manner. Accordingly, in vivo production of endogenous PPARα ligands, triggered by α7-nAChR activation, blocks in rats nicotine-induced increased firing activity of dopamine neurons and displays antidepressant-like properties. These data demonstrate that endogenous PPARα ligands are effectors of α7-nAChRs and that their neuromodulatory properties depend on phosphorylation of β2*-nAChRs on VTA dopamine cells. This reveals an autoinhibitory mechanism aimed at reducing dopamine cell overexcitation engaged during hypercholinergic drive. Our results unveil important physiological functions of nAChR/PPARα signaling in dopamine neurons and how behavioral output can change after modifications of this signaling pathway. Overall, the present study suggests PPARα as new therapeutic targets for disorders associated with unbalanced dopamine–acetylcholine systems.
Ventral tegmental area dopamine neurons control reward-driven learning, and their dysregulation can lead to psychiatric disorders. Tonic and phasic activity of these dopaminergic neurons depends on cholinergic tone and activation of nicotinic acetylcholine receptors (nAChRs), particularly those containing the β2 subunit (β2*-nAChRs). Nuclear peroxisome proliferator-activated receptors type-α (PPARα) tonically regulate β2*-nAChRs and thereby control dopamine neuron firing activity. However, it is unknown how and when PPARα endogenous ligands are synthesized by dopamine cells. Using ex vivo and in vivo electrophysiological techniques combined with biochemical and behavioral analysis, we show that activation of α7-nAChRs increases in the rat VTA both the tyrosine phosphorylation of the β2 subunit of nAChRs and the levels of two PPARα endogenous ligands in a Ca(2+)-dependent manner. Accordingly, in vivo production of endogenous PPARα ligands, triggered by α7-nAChR activation, blocks in rats nicotine-induced increased firing activity of dopamine neurons and displays antidepressant-like properties. These data demonstrate that endogenous PPARα ligands are effectors of α7-nAChRs and that their neuromodulatory properties depend on phosphorylation of β2*-nAChRs on VTA dopamine cells. This reveals an autoinhibitory mechanism aimed at reducing dopamine cell overexcitation engaged during hypercholinergic drive. Our results unveil important physiological functions of nAChR/PPARα signaling in dopamine neurons and how behavioral output can change after modifications of this signaling pathway. Overall, the present study suggests PPARα as new therapeutic targets for disorders associated with unbalanced dopamine-acetylcholine systems.Ventral tegmental area dopamine neurons control reward-driven learning, and their dysregulation can lead to psychiatric disorders. Tonic and phasic activity of these dopaminergic neurons depends on cholinergic tone and activation of nicotinic acetylcholine receptors (nAChRs), particularly those containing the β2 subunit (β2*-nAChRs). Nuclear peroxisome proliferator-activated receptors type-α (PPARα) tonically regulate β2*-nAChRs and thereby control dopamine neuron firing activity. However, it is unknown how and when PPARα endogenous ligands are synthesized by dopamine cells. Using ex vivo and in vivo electrophysiological techniques combined with biochemical and behavioral analysis, we show that activation of α7-nAChRs increases in the rat VTA both the tyrosine phosphorylation of the β2 subunit of nAChRs and the levels of two PPARα endogenous ligands in a Ca(2+)-dependent manner. Accordingly, in vivo production of endogenous PPARα ligands, triggered by α7-nAChR activation, blocks in rats nicotine-induced increased firing activity of dopamine neurons and displays antidepressant-like properties. These data demonstrate that endogenous PPARα ligands are effectors of α7-nAChRs and that their neuromodulatory properties depend on phosphorylation of β2*-nAChRs on VTA dopamine cells. This reveals an autoinhibitory mechanism aimed at reducing dopamine cell overexcitation engaged during hypercholinergic drive. Our results unveil important physiological functions of nAChR/PPARα signaling in dopamine neurons and how behavioral output can change after modifications of this signaling pathway. Overall, the present study suggests PPARα as new therapeutic targets for disorders associated with unbalanced dopamine-acetylcholine systems.
Author Fratta, Walter
Fadda, Paola
Melis, Miriam
Scheggi, Simona
Castelli, M Paola
Cadeddu, Francesca
De Montis, M Graziella
Ennas, M Grazia
Pistis, Marco
Schilstrom, Bjorn
Madeddu, Camilla
Frau, Roberto
Banni, Sebastiano
Luchicchi, Antonio
Lecca, Salvatore
Fattore, Liana
Carta, Gianfranca
Author_xml – sequence: 1
  givenname: Miriam
  surname: Melis
  fullname: Melis, Miriam
  email: myriam@unica.it
  organization: Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria di Monserrato, 09042 Monserrato, Italy. myriam@unica.it
– sequence: 2
  givenname: Simona
  surname: Scheggi
  fullname: Scheggi, Simona
– sequence: 3
  givenname: Gianfranca
  surname: Carta
  fullname: Carta, Gianfranca
– sequence: 4
  givenname: Camilla
  surname: Madeddu
  fullname: Madeddu, Camilla
– sequence: 5
  givenname: Salvatore
  surname: Lecca
  fullname: Lecca, Salvatore
– sequence: 6
  givenname: Antonio
  surname: Luchicchi
  fullname: Luchicchi, Antonio
– sequence: 7
  givenname: Francesca
  surname: Cadeddu
  fullname: Cadeddu, Francesca
– sequence: 8
  givenname: Roberto
  surname: Frau
  fullname: Frau, Roberto
– sequence: 9
  givenname: Liana
  surname: Fattore
  fullname: Fattore, Liana
– sequence: 10
  givenname: Paola
  surname: Fadda
  fullname: Fadda, Paola
– sequence: 11
  givenname: M Grazia
  surname: Ennas
  fullname: Ennas, M Grazia
– sequence: 12
  givenname: M Paola
  surname: Castelli
  fullname: Castelli, M Paola
– sequence: 13
  givenname: Walter
  surname: Fratta
  fullname: Fratta, Walter
– sequence: 14
  givenname: Bjorn
  surname: Schilstrom
  fullname: Schilstrom, Bjorn
– sequence: 15
  givenname: Sebastiano
  surname: Banni
  fullname: Banni, Sebastiano
– sequence: 16
  givenname: M Graziella
  surname: De Montis
  fullname: De Montis, M Graziella
– sequence: 17
  givenname: Marco
  surname: Pistis
  fullname: Pistis, Marco
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23554501$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:126515970$$DView record from Swedish Publication Index
BookMark eNpVUtFu2yAURVOnNe32CxWPe3EGBpvwMqmK2q1TtVbd-owwXCdsNmRge8pX7Fv6I_2mESWL1gfg6txzzr0S5wyd-OABoQtK5rQq2YcvX68eH-6-LW_mvOaioOW8JJS9QrPclUXJCT1BM1IKUuQ2P0VnKf0ghAhCxRt0WrKq4hWhM_Tn_v7y4fkJR1iNnR4gYbMOnfMQV84UNroJPNZmcJMbtji0uHe2idp5bMNG95mIPYwx-IQnp7HGPkzQ4R7MWnuXeuz8FLrJ-RV-fhLYOxMGl-_sCcO2OwzL4w1shhDTW_S61V2Cd4f3HD1eX31ffi5u7z7dLC9vC8OEZEWjS8rbxiyo0G1L26axwLhdUGu11KUVGeDGSF7bSoo6QwJAMi5AEtlm7jmSe9_0GzZjozbR9TpuVdAu18GqA_7T7Y5KoGhZVzSbkaz9uNdmQg_WgB-i7l5avOh4t1arMKm6pgvJFtng_cEghl8jpEH1LhnoOu0hjElRVnK2qCRjmVrvqSaGlCK0xzGUqF0S1DEJapeEvKbaJSELL_5f8ij79_XsLzuCupY
CitedBy_id crossref_primary_10_1523_JNEUROSCI_2810_16_2017
crossref_primary_10_3389_fnsyn_2020_588660
crossref_primary_10_1016_j_bbr_2016_06_022
crossref_primary_10_1016_j_toxlet_2018_12_002
crossref_primary_10_1016_j_brainresbull_2019_02_003
crossref_primary_10_1111_nyas_12421
crossref_primary_10_1016_j_bbr_2019_03_019
crossref_primary_10_3390_biom10020226
crossref_primary_10_3390_molecules26040998
crossref_primary_10_1007_s00213_015_4196_3
crossref_primary_10_1016_j_expneurol_2017_06_014
crossref_primary_10_1523_ENEURO_0286_21_2022
crossref_primary_10_1016_j_neuropharm_2017_01_007
crossref_primary_10_3390_ijms22094299
crossref_primary_10_1016_j_coph_2020_08_014
crossref_primary_10_1016_j_lfs_2018_10_045
crossref_primary_10_1038_npp_2014_268
crossref_primary_10_1016_j_neuroscience_2017_03_056
crossref_primary_10_1016_j_phrs_2014_03_006
crossref_primary_10_1038_s42003_023_05295_y
crossref_primary_10_1021_cn500126t
crossref_primary_10_1016_j_neuropharm_2018_11_013
crossref_primary_10_1016_j_phrs_2014_03_009
crossref_primary_10_3390_nu10101347
crossref_primary_10_1016_j_neuropharm_2013_09_008
crossref_primary_10_1016_j_neuropharm_2017_03_005
crossref_primary_10_1016_j_phrs_2014_05_006
crossref_primary_10_3390_cells10030586
crossref_primary_10_1016_j_jad_2018_02_057
crossref_primary_10_1016_j_neuropharm_2020_108225
crossref_primary_10_1038_s41380_024_02427_6
crossref_primary_10_3390_biom12050723
crossref_primary_10_3390_brainsci12111493
crossref_primary_10_1038_npp_2015_62
crossref_primary_10_1016_j_neuropharm_2014_05_010
crossref_primary_10_1016_j_neuropharm_2018_03_020
crossref_primary_10_2174_1871527323666230904150841
crossref_primary_10_1038_s41593_019_0512_2
crossref_primary_10_1172_jci_insight_150099
crossref_primary_10_1016_j_intimp_2017_09_023
crossref_primary_10_1371_journal_pone_0064541
crossref_primary_10_1016_j_neuroscience_2014_05_040
crossref_primary_10_1016_j_envint_2018_03_025
crossref_primary_10_1007_s00213_018_5020_7
crossref_primary_10_1021_acs_analchem_2c02650
crossref_primary_10_3389_fphar_2020_587140
crossref_primary_10_1186_s13229_020_00358_x
crossref_primary_10_1038_s41398_018_0130_x
crossref_primary_10_3389_fphar_2021_653175
crossref_primary_10_1089_can_2022_0005
crossref_primary_10_1007_s12031_017_1002_1
crossref_primary_10_1021_acschemneuro_3c00320
crossref_primary_10_1186_s40001_024_01700_2
crossref_primary_10_4103_1673_5374_165313
crossref_primary_10_1016_j_neuron_2023_08_017
crossref_primary_10_1016_j_neuropharm_2016_07_024
crossref_primary_10_1002_phar_2073
crossref_primary_10_1016_j_euroneuro_2019_09_009
crossref_primary_10_1016_j_bbr_2018_09_020
crossref_primary_10_1016_j_addicn_2023_100103
crossref_primary_10_1016_j_bcp_2015_07_014
crossref_primary_10_1016_j_pnpbp_2018_05_018
crossref_primary_10_1093_ntr_ntv085
Cites_doi 10.1042/0264-6021:3580249
10.1038/nature01921
10.1016/j.biopsych.2010.07.009
10.1002/cne.902160406
10.1046/j.1471-4159.1998.70041366.x
10.1073/pnas.0509591102
10.1186/1479-5876-9-129
10.1111/j.1460-9568.2007.05887.x
10.1016/j.biopsych.2004.08.010
10.1523/JNEUROSCI.21-05-01452.2001
10.1016/j.physbeh.2012.03.020
10.1016/S0891-0618(00)00109-5
10.1038/sj.npp.1301188
10.1523/JNEUROSCI.13-02-00596.1993
10.1017/S1461145702003188
10.1523/JNEUROSCI.05-05-01307.1985
10.1124/mol.106.025130
10.2174/138161210790170094
10.1097/00001756-199412000-00019
10.1097/FBP.0b013e32832c713e
10.1523/JNEUROSCI.5671-10.2011
10.1038/34413
10.1007/s00018-010-0525-1
10.1016/j.neuropharm.2008.11.006
10.1038/npp.2011.302
10.1100/2012/104105
10.1371/journal.pone.0015222
10.1080/15504260902869964
10.1038/266730a0
10.1111/j.1460-9568.2004.03428.x
10.1113/jphysiol.2008.162743
10.1016/j.biopsych.2010.04.016
10.1007/s00213-006-0527-8
10.1126/science.6828889
10.1016/j.schres.2012.01.005
10.1038/npp.2012.31
10.1002/da.10035
10.2174/1568007023339184
10.1016/S0009-3084(00)00190-0
10.1016/j.bmcl.2008.04.070
10.1002/syn.20733
10.1046/j.1471-4159.2002.01005.x
10.1016/j.tips.2010.09.004
10.1038/35102582
10.1073/pnas.90.15.6971
10.1371/journal.pone.0017047
10.1016/j.physbeh.2011.04.052
10.1186/1743-7075-8-51
10.1016/S1734-1140(11)70596-5
10.1124/mol.104.006353
10.1523/JNEUROSCI.23-08-03176.2003
10.1016/j.nbd.2006.04.010
10.1016/j.biopsych.2006.12.001
10.1021/jm050069n
10.2174/1871527311312010012
10.1016/j.euroneuro.2012.07.007
10.1016/S0014-2999(01)01182-7
10.1523/JNEUROSCI.3221-08.2008
10.1007/s00213-010-1932-6
10.1016/j.neuron.2006.05.007
10.1155/2012/839853
10.1113/jphysiol.2003.053447
10.2174/1568026043451401
10.1002/0471142301.ns0810as55
10.1194/jlr.M700354-JLR200
10.1016/j.clinph.2011.11.033
10.1523/JNEUROSCI.3009-04.2004
10.1097/FBP.0b013e328347546d
10.1007/s12640-010-9166-2
10.1016/j.neuropharm.2010.06.004
10.1073/pnas.0510715103
10.1021/jm300247y
10.1016/j.bbr.2011.04.031
10.1016/S0140-6736(72)93021-8
10.2174/092986710790980014
ContentType Journal Article
Copyright Copyright © 2013 the authors 0270-6474/13/336203-09$15.00/0 2013
Copyright_xml – notice: Copyright © 2013 the authors 0270-6474/13/336203-09$15.00/0 2013
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
ADTPV
AOWAS
D8T
ZZAVC
DOI 10.1523/JNEUROSCI.4647-12.2013
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Freely available online
SwePub Articles full text
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1529-2401
EndPage 6211
ExternalDocumentID oai_prod_swepub_kib_ki_se_126515970
10_1523_JNEUROSCI_4647_12_2013
23554501
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-DZ
-~X
.55
18M
2WC
34G
39C
53G
5GY
5RE
5VS
AAFWJ
ABBAR
ABIVO
ACGUR
ACNCT
ADBBV
ADCOW
AENEX
AFCFT
AFHIN
AFOSN
AHWXS
AIZTS
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
GX1
H13
HYE
H~9
KQ8
L7B
MVM
NPM
OK1
P0W
P2P
QZG
R.V
RHF
RHI
RPM
TFN
TR2
W8F
WH7
WOQ
X7M
XJT
YBU
YHG
YKV
YNH
YSK
AAYXX
CITATION
7X8
AETEA
5PM
.GJ
1CY
3O-
ADTPV
AFFNX
AI.
AOWAS
D8T
RIG
VH1
YYP
ZGI
ZXP
ZZAVC
ID FETCH-LOGICAL-c3793-ba214fbc817aff1fbbde34d81dda9a2d7bbd4cc946d59769a27ee9347e909fde3
IEDL.DBID RPM
ISSN 0270-6474
1529-2401
IngestDate Sun Oct 13 03:42:52 EDT 2024
Tue Sep 17 21:17:02 EDT 2024
Sat Aug 17 04:32:21 EDT 2024
Thu Sep 26 18:06:10 EDT 2024
Sun Oct 13 09:40:55 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 14
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3793-ba214fbc817aff1fbbde34d81dda9a2d7bbd4cc946d59769a27ee9347e909fde3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Author contributions: M.M., M.G.E., M.P.C., W.F., B.S., S.B., M.G.D.M., and M.P. designed research; M.M., S.S., G.C., C.M., S.L., A.L., F.C., R.F., L.F., and B.S. performed research; M.M., S.S., S.L., R.F., L.F., P.F., M.G.E., M.P.C., S.B., and M.G.D.M. analyzed data; M.M. wrote the paper.
OpenAccessLink http://kipublications.ki.se/Default.aspx?queryparsed=id:126515970
PMID 23554501
PQID 1324385933
PQPubID 23479
PageCount 9
ParticipantIDs swepub_primary_oai_prod_swepub_kib_ki_se_126515970
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6618938
proquest_miscellaneous_1324385933
crossref_primary_10_1523_JNEUROSCI_4647_12_2013
pubmed_primary_23554501
PublicationCentury 2000
PublicationDate 2013-04-03
PublicationDateYYYYMMDD 2013-04-03
PublicationDate_xml – month: 04
  year: 2013
  text: 2013-04-03
  day: 03
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of neuroscience
PublicationTitleAlternate J Neurosci
PublicationYear 2013
Publisher Society for Neuroscience
Publisher_xml – name: Society for Neuroscience
References 2023041304031030000_33.14.6203.39
2023041304031030000_33.14.6203.46
2023041304031030000_33.14.6203.45
2023041304031030000_33.14.6203.48
2023041304031030000_33.14.6203.47
2023041304031030000_33.14.6203.42
2023041304031030000_33.14.6203.41
2023041304031030000_33.14.6203.44
2023041304031030000_33.14.6203.1
2023041304031030000_33.14.6203.43
2023041304031030000_33.14.6203.4
2023041304031030000_33.14.6203.3
2023041304031030000_33.14.6203.6
2023041304031030000_33.14.6203.40
2023041304031030000_33.14.6203.5
2023041304031030000_33.14.6203.8
2023041304031030000_33.14.6203.7
2023041304031030000_33.14.6203.9
Klink (2023041304031030000_33.14.6203.26) 2001; 21
Yu (2023041304031030000_33.14.6203.77) 2011; 63
2023041304031030000_33.14.6203.49
Séguéla (2023041304031030000_33.14.6203.67) 1993; 13
Philip (2023041304031030000_33.14.6203.54) 2012; 2012
2023041304031030000_33.14.6203.13
2023041304031030000_33.14.6203.57
Marks (2023041304031030000_33.14.6203.38) 1985; 235
2023041304031030000_33.14.6203.56
2023041304031030000_33.14.6203.15
2023041304031030000_33.14.6203.59
2023041304031030000_33.14.6203.14
2023041304031030000_33.14.6203.58
2023041304031030000_33.14.6203.53
2023041304031030000_33.14.6203.52
2023041304031030000_33.14.6203.11
2023041304031030000_33.14.6203.55
2023041304031030000_33.14.6203.10
2023041304031030000_33.14.6203.51
2023041304031030000_33.14.6203.50
Janowsky (2023041304031030000_33.14.6203.23) 1972; 2
Wooltorton (2023041304031030000_33.14.6203.75) 2003; 23
Adamczyk (2023041304031030000_33.14.6203.2) 2008; 59
Salín-Pascual (2023041304031030000_33.14.6203.63) 1996; 57
Clarke (2023041304031030000_33.14.6203.12) 1985; 5
2023041304031030000_33.14.6203.17
2023041304031030000_33.14.6203.16
2023041304031030000_33.14.6203.19
2023041304031030000_33.14.6203.18
2023041304031030000_33.14.6203.24
2023041304031030000_33.14.6203.68
2023041304031030000_33.14.6203.25
2023041304031030000_33.14.6203.69
2023041304031030000_33.14.6203.20
2023041304031030000_33.14.6203.64
2023041304031030000_33.14.6203.22
2023041304031030000_33.14.6203.66
2023041304031030000_33.14.6203.21
2023041304031030000_33.14.6203.65
2023041304031030000_33.14.6203.60
2023041304031030000_33.14.6203.62
2023041304031030000_33.14.6203.61
2023041304031030000_33.14.6203.28
2023041304031030000_33.14.6203.27
2023041304031030000_33.14.6203.29
2023041304031030000_33.14.6203.35
2023041304031030000_33.14.6203.79
2023041304031030000_33.14.6203.34
2023041304031030000_33.14.6203.78
2023041304031030000_33.14.6203.37
2023041304031030000_33.14.6203.36
2023041304031030000_33.14.6203.31
2023041304031030000_33.14.6203.30
2023041304031030000_33.14.6203.74
2023041304031030000_33.14.6203.33
2023041304031030000_33.14.6203.32
2023041304031030000_33.14.6203.76
2023041304031030000_33.14.6203.71
2023041304031030000_33.14.6203.70
2023041304031030000_33.14.6203.73
2023041304031030000_33.14.6203.72
References_xml – ident: 2023041304031030000_33.14.6203.16
  doi: 10.1042/0264-6021:3580249
– ident: 2023041304031030000_33.14.6203.18
  doi: 10.1038/nature01921
– ident: 2023041304031030000_33.14.6203.39
  doi: 10.1016/j.biopsych.2010.07.009
– ident: 2023041304031030000_33.14.6203.3
  doi: 10.1002/cne.902160406
– ident: 2023041304031030000_33.14.6203.15
  doi: 10.1046/j.1471-4159.1998.70041366.x
– ident: 2023041304031030000_33.14.6203.21
  doi: 10.1073/pnas.0509591102
– ident: 2023041304031030000_33.14.6203.29
  doi: 10.1186/1479-5876-9-129
– ident: 2023041304031030000_33.14.6203.41
  doi: 10.1111/j.1460-9568.2007.05887.x
– ident: 2023041304031030000_33.14.6203.10
  doi: 10.1016/j.biopsych.2004.08.010
– volume: 21
  start-page: 1452
  year: 2001
  ident: 2023041304031030000_33.14.6203.26
  article-title: Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.21-05-01452.2001
  contributor:
    fullname: Klink
– ident: 2023041304031030000_33.14.6203.6
  doi: 10.1016/j.physbeh.2012.03.020
– ident: 2023041304031030000_33.14.6203.17
  doi: 10.1016/S0891-0618(00)00109-5
– ident: 2023041304031030000_33.14.6203.56
  doi: 10.1038/sj.npp.1301188
– volume: 59
  start-page: 217
  year: 2008
  ident: 2023041304031030000_33.14.6203.2
  article-title: Activation of endocannabinoid transmission induces antidepressant-like effects in rats
  publication-title: J Physiol Pharmacol
  contributor:
    fullname: Adamczyk
– volume: 13
  start-page: 596
  year: 1993
  ident: 2023041304031030000_33.14.6203.67
  article-title: Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.13-02-00596.1993
  contributor:
    fullname: Séguéla
– ident: 2023041304031030000_33.14.6203.64
  doi: 10.1017/S1461145702003188
– volume: 5
  start-page: 1307
  year: 1985
  ident: 2023041304031030000_33.14.6203.12
  article-title: Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.05-05-01307.1985
  contributor:
    fullname: Clarke
– ident: 2023041304031030000_33.14.6203.45
  doi: 10.1124/mol.106.025130
– ident: 2023041304031030000_33.14.6203.70
  doi: 10.2174/138161210790170094
– ident: 2023041304031030000_33.14.6203.25
  doi: 10.1097/00001756-199412000-00019
– ident: 2023041304031030000_33.14.6203.4
  doi: 10.1097/FBP.0b013e32832c713e
– ident: 2023041304031030000_33.14.6203.35
  doi: 10.1523/JNEUROSCI.5671-10.2011
– ident: 2023041304031030000_33.14.6203.55
  doi: 10.1038/34413
– ident: 2023041304031030000_33.14.6203.7
  doi: 10.1007/s00018-010-0525-1
– ident: 2023041304031030000_33.14.6203.19
  doi: 10.1016/j.neuropharm.2008.11.006
– ident: 2023041304031030000_33.14.6203.31
  doi: 10.1038/npp.2011.302
– volume: 2012
  start-page: 104105
  year: 2012
  ident: 2023041304031030000_33.14.6203.54
  article-title: The nicotinic acetylcholine receptor as a target for antidepressant drug development
  publication-title: Sci World J
  doi: 10.1100/2012/104105
  contributor:
    fullname: Philip
– ident: 2023041304031030000_33.14.6203.36
  doi: 10.1371/journal.pone.0015222
– ident: 2023041304031030000_33.14.6203.46
  doi: 10.1080/15504260902869964
– ident: 2023041304031030000_33.14.6203.60
  doi: 10.1038/266730a0
– ident: 2023041304031030000_33.14.6203.22
  doi: 10.1111/j.1460-9568.2004.03428.x
– ident: 2023041304031030000_33.14.6203.76
  doi: 10.1113/jphysiol.2008.162743
– ident: 2023041304031030000_33.14.6203.43
  doi: 10.1016/j.biopsych.2010.04.016
– ident: 2023041304031030000_33.14.6203.30
  doi: 10.1007/s00213-006-0527-8
– ident: 2023041304031030000_33.14.6203.66
  doi: 10.1126/science.6828889
– volume: 57
  start-page: 387
  year: 1996
  ident: 2023041304031030000_33.14.6203.63
  article-title: Antidepressant effect of transdermal nicotine patches in nonsmoking patients with major depression
  publication-title: J Clin Psychiatry
  contributor:
    fullname: Salín-Pascual
– ident: 2023041304031030000_33.14.6203.28
  doi: 10.1016/j.schres.2012.01.005
– ident: 2023041304031030000_33.14.6203.50
  doi: 10.1038/npp.2012.31
– ident: 2023041304031030000_33.14.6203.68
  doi: 10.1002/da.10035
– ident: 2023041304031030000_33.14.6203.20
  doi: 10.2174/1568007023339184
– ident: 2023041304031030000_33.14.6203.71
  doi: 10.1016/S0009-3084(00)00190-0
– ident: 2023041304031030000_33.14.6203.1
  doi: 10.1016/j.bmcl.2008.04.070
– ident: 2023041304031030000_33.14.6203.59
  doi: 10.1002/syn.20733
– ident: 2023041304031030000_33.14.6203.74
  doi: 10.1046/j.1471-4159.2002.01005.x
– ident: 2023041304031030000_33.14.6203.47
  doi: 10.1016/j.tips.2010.09.004
– ident: 2023041304031030000_33.14.6203.61
  doi: 10.1038/35102582
– ident: 2023041304031030000_33.14.6203.8
  doi: 10.1073/pnas.90.15.6971
– ident: 2023041304031030000_33.14.6203.73
  doi: 10.1371/journal.pone.0017047
– ident: 2023041304031030000_33.14.6203.37
  doi: 10.1016/j.physbeh.2011.04.052
– ident: 2023041304031030000_33.14.6203.57
  doi: 10.1186/1743-7075-8-51
– volume: 63
  start-page: 834
  year: 2011
  ident: 2023041304031030000_33.14.6203.77
  article-title: N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice
  publication-title: Pharmacol Rep
  doi: 10.1016/S1734-1140(11)70596-5
  contributor:
    fullname: Yu
– ident: 2023041304031030000_33.14.6203.33
  doi: 10.1124/mol.104.006353
– volume: 23
  start-page: 3176
  year: 2003
  ident: 2023041304031030000_33.14.6203.75
  article-title: Differential desensitization and distribution of nicotinic acetylcholine receptor subtypes in midbrain dopamine areas
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.23-08-03176.2003
  contributor:
    fullname: Wooltorton
– ident: 2023041304031030000_33.14.6203.40
  doi: 10.1016/j.nbd.2006.04.010
– ident: 2023041304031030000_33.14.6203.9
  doi: 10.1016/j.biopsych.2006.12.001
– ident: 2023041304031030000_33.14.6203.13
  doi: 10.1021/jm050069n
– ident: 2023041304031030000_33.14.6203.44
  doi: 10.2174/1871527311312010012
– ident: 2023041304031030000_33.14.6203.14
  doi: 10.1016/j.euroneuro.2012.07.007
– ident: 2023041304031030000_33.14.6203.69
  doi: 10.1016/S0014-2999(01)01182-7
– ident: 2023041304031030000_33.14.6203.42
  doi: 10.1523/JNEUROSCI.3221-08.2008
– ident: 2023041304031030000_33.14.6203.53
  doi: 10.1007/s00213-010-1932-6
– ident: 2023041304031030000_33.14.6203.34
  doi: 10.1016/j.neuron.2006.05.007
– ident: 2023041304031030000_33.14.6203.62
  doi: 10.1155/2012/839853
– ident: 2023041304031030000_33.14.6203.51
  doi: 10.1113/jphysiol.2003.053447
– ident: 2023041304031030000_33.14.6203.52
– volume: 235
  start-page: 619
  year: 1985
  ident: 2023041304031030000_33.14.6203.38
  article-title: Time course study of the effects of chronic nicotine infusion on drug response and brain receptors
  publication-title: J Pharmacol Exp Ther
  contributor:
    fullname: Marks
– ident: 2023041304031030000_33.14.6203.49
  doi: 10.2174/1568026043451401
– ident: 2023041304031030000_33.14.6203.11
  doi: 10.1002/0471142301.ns0810as55
– ident: 2023041304031030000_33.14.6203.5
  doi: 10.1194/jlr.M700354-JLR200
– ident: 2023041304031030000_33.14.6203.65
  doi: 10.1016/j.clinph.2011.11.033
– ident: 2023041304031030000_33.14.6203.24
  doi: 10.1523/JNEUROSCI.3009-04.2004
– ident: 2023041304031030000_33.14.6203.48
  doi: 10.1097/FBP.0b013e328347546d
– ident: 2023041304031030000_33.14.6203.27
  doi: 10.1007/s12640-010-9166-2
– ident: 2023041304031030000_33.14.6203.79
  doi: 10.1016/j.neuropharm.2010.06.004
– ident: 2023041304031030000_33.14.6203.32
  doi: 10.1073/pnas.0510715103
– ident: 2023041304031030000_33.14.6203.78
  doi: 10.1021/jm300247y
– ident: 2023041304031030000_33.14.6203.72
  doi: 10.1016/j.bbr.2011.04.031
– volume: 2
  start-page: 632
  year: 1972
  ident: 2023041304031030000_33.14.6203.23
  article-title: A cholinergic-adrenergic hypothesis of mania and depression
  publication-title: Lancet
  doi: 10.1016/S0140-6736(72)93021-8
  contributor:
    fullname: Janowsky
– ident: 2023041304031030000_33.14.6203.58
  doi: 10.2174/092986710790980014
SSID ssj0007017
Score 2.438751
Snippet Ventral tegmental area dopamine neurons control reward-driven learning, and their dysregulation can lead to psychiatric disorders. Tonic and phasic activity of...
SourceID swepub
pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 6203
SubjectTerms Action Potentials - drug effects
alpha7 Nicotinic Acetylcholine Receptor
Analysis of Variance
Animals
Animals, Newborn
Benzamides - pharmacology
Bridged Bicyclo Compounds - pharmacology
Carbamates - pharmacology
Cholinergic Agents - pharmacology
Dihydro-beta-Erythroidine - pharmacology
Dopaminergic Neurons - drug effects
Dopaminergic Neurons - physiology
Drug Interactions
Enzyme Inhibitors - pharmacology
Ethanolamines - metabolism
Excitatory Amino Acid Antagonists - pharmacology
In Vitro Techniques
Ligands
Male
Medicin och hälsovetenskap
Patch-Clamp Techniques
PPAR alpha - agonists
PPAR alpha - metabolism
Pyrimidines - pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Nicotinic - metabolism
Swimming - psychology
Tyrosine 3-Monooxygenase - metabolism
Ventral Tegmental Area - cytology
Title PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors
URI https://www.ncbi.nlm.nih.gov/pubmed/23554501
https://www.proquest.com/docview/1324385933/abstract/
https://pubmed.ncbi.nlm.nih.gov/PMC6618938
http://kipublications.ki.se/Default.aspx?queryparsed=id:126515970
Volume 33
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECWSnHop2qaLuwQsUPQmayElWkfDaRCnsGGkDZAbIW6IUEsKLCdAvqLfkh_JN3WGkgwYufXgC0WTAt6Qw0fNzCPkm7WZKVjqgJsADNy4NMiVmgSZSy1jynHnM7wXy-z8il9cp9cHJB1yYXzQvlbluF5X47q88bGVt5UOhzixcLWYgU8BNzsJD8mhYGyg6P32KyIvswt0C3gRF7xPCwbCFV4sMTzu12w-5vAkiDERK0YlnQS9btoLw-yc07MT5_PAyb3yot4lnb0iL_uzJJ127_yaHNj6DTme1sCjqwf6nfroTn9tfkz-rlbTy6dHetlpz9uWzm5Qr8duYOsLTje46dGp7rQkaOPoojQK5SPoKdDqCjpSX8ejbul9WdCCLpt7u6YLi5nDZVvReQ0bHd5O0KdHQdHAtphzCWPa7cNad5PB9BhG02zat-Tq7Mfv2XnQizEEmsEaDlSRxNwpPYlF4VzslDKWcQPHXVPkRWIENHCtc54Z4CgZNAlrc8aFzaPcQd935KhuavuBUJ6YDOxA8yRyPHZG6QJvizhnk8wBwRqRcEBB3nY1NyRyFYBQ7iCUCKGME4kQjsjXASwJywO_eRS1be5aCWQbhk1zBn3ed-DtxhxQHxGxB-uuA5be3n8CFulLcPcWOCJJZwD7fwHXJ_v2PyX-ZGvhVVF1PhfRx_-e7hN5kXg1Dh5E7DM52m7u7Bc4E23VCbCB-c8TvxL-AbLREZM
link.rule.ids 230,315,733,786,790,891,27955,27956,53825,53827
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbtswECXSdNFumrbpx_2yQNGdZH0oyVoaTgM7jQwjTYrsCJEiESGWFFhygOQSPUsukjN1hpIMuFm1C21IirTARw4fPTOPkK9KhVnqBxq4CUwDy3RgxUKMrFAHyveFZtpEeCfzcHrGjs6D8x0S9LEwxmlfitwul4Vd5hfGt_KqkMPeT2y4SCZgU8DMjoaPyGNYr17Qk_RuA44cI7QLhAuYEYtYFxgMlGt4NEcHuZ-Tmc2gxnIxFMtFLR0P7W7QScNszNODM-dD18mtBKPGKB3ukV_957S-KJf2uhG2vP0r0-M_f-9z8qw7ptJxW_2C7KjyJdkfl0DRixv6jRrHUXMjv09-Lxbjk_s7etLK2quaTi5QCkitYFe1Dla4n9KxbGUqaKVpkmcClSnoATD2AhpSkyKkrOl1ntKUzqtrtaSJwqDkvC7orIQ9FC8-6P1dRBG7DYZzQp-quVnKdjAYHj10qlX9ipwdfj-dTK1O58GSPmwPlkg9l2khR26Uau1qITLlswxO0lkap14WQQGTMmZhBvQnhKJIqdhnkYqdWEPb12S3rEr1llDmZSFATDLP0czVmZApXkQx5o9CDdxtQIb99PKrNp0HRxoE2OAbbHDEBnc9jtgYkC89CjisPPw7JS1Vta458HjoNoh9aPOmRcWmzx5OAxJt4WXTALN6b9fA5Jvs3t1kD4jXImv7FbCqvCu_zPHhtYKfioL2ceS8--_hPpMn09PkmB_P5j_ek6eeEf1gluN_ILvNaq0-wtGrEZ_MQvsDXBcymQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbtswECXaFCh66ZYu7soCRW_aKdE6GnaNOK0NI22AoBdC3BAhlmRYcoD0J_ot-ZF8U4eUZNTNLQdfqDFpgY8cPnpmHkKflUpkFsUauAlMA5E6dlLOh06iYxVFXBNtM7zni-TolByfxWf_SH3ZoH3Bc7dcFW6Zn9vYynUhvD5OzFvOx-BTwM0OvbXU3n30ANZsSHui3m3C1Ldiu0C6gB0RSrrkYKBd3vHCBMn9GM9cAk-cwKRjBUZPJzS-N-7kYXYu6ta583b45F6RUeuYpk_Qr_6V2niUC3fbcFf8_q_a453e-Sl63B1X8ag1eYbuqfI5OhyVQNWLK_wF2wBSezN_iP4sl6OTm2t80srbqxqPz40kkNrA7upMNmZfxSPRylXgSuN5LrlRqMATYO4FGGJbKqSs8WWe4Qwvqku1wnNlkpPzusCzEvZScwGCb64pNhhuTFon9Kmaq5VoB4PhTaROtalfoNPp15_jI6fTe3BEBNuEw7MwIJqLYUAzrQPNuVQRkXCillmahZJCAxEiJYkEGpRAE1UqjQhVqZ9qsH2JDsqqVK8RJqFMAGqChL4mgZZcZOZCipBomGjgcAPk9VPM1m1ZD2boEOCD7fDBDD5YEDKDjwH61COBwQo0f6tkpaq2NQM-D93GaQQ2r1pk7PrsITVAdA8zOwNT3Xv_CQDAVvnuJnyAwhZd-18B78q69ovcfFit4KcaYfuU-m_uPNxH9HA5mbLvs8W3t-hRaLU_iONH79BBs9mq93ACa_gHu9b-Ar6VNRk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PPAR%CE%B1+Regulates+Cholinergic-Driven+Activity+of+Midbrain+Dopamine+Neurons+via+a+Novel+Mechanism+Involving+%CE%B17+Nicotinic+Acetylcholine+Receptors&rft.jtitle=The+Journal+of+neuroscience&rft.au=Melis%2C+Miriam&rft.au=Scheggi%2C+Simona&rft.au=Carta%2C+Gianfranca&rft.au=Madeddu%2C+Camilla&rft.date=2013-04-03&rft.pub=Society+for+Neuroscience&rft.issn=0270-6474&rft.eissn=1529-2401&rft.volume=33&rft.issue=14&rft.spage=6203&rft.epage=6211&rft_id=info:doi/10.1523%2FJNEUROSCI.4647-12.2013&rft_id=info%3Apmid%2F23554501&rft.externalDBID=PMC6618938
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-6474&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-6474&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-6474&client=summon